当前位置:首页 - 行情中心 - 乐普医疗(300003) - 财务分析 - 资产负债表

乐普医疗

(300003)

  

流通市值:182.94亿  总市值:212.89亿
流通股本:16.16亿   总股本:18.81亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金3,729,685,667.043,718,016,911.133,340,861,662.253,609,445,553.31
应收票据及应收账款1,958,982,308.781,647,405,051.562,001,318,591.352,167,593,831.01
其中:应收票据101,799,300.04116,747,820.08102,456,414.5493,024,769.88
应收账款1,857,183,008.741,530,657,231.481,898,862,176.812,074,569,061.13
应收款项融资125,879,359.27159,509,608.7107,981,361.6654,165,212.46
预付款项274,317,299.3226,737,694.48301,135,787.35317,762,713.1
其他应收款合计115,331,369.16114,401,883.63142,672,052.49155,668,664.95
存货1,977,616,736.792,030,235,942.182,216,459,996.882,265,395,093.91
一年内到期的非流动资产212,401,339.1833,010,145.092,235,269.543,635,751.97
其他流动资产253,053,966.18232,101,603.89207,609,262.17199,945,164.46
流动资产平衡项目0000
流动资产合计9,006,816,747.618,436,281,703.628,732,636,190.039,213,054,214.62
非流动资产:
长期应收款-189,453.63935,793.46789,854.8
长期股权投资1,212,784,329.491,189,771,189.431,200,559,023.471,260,462,826.16
其他权益工具投资1,079,299,413.041,086,887,464.611,100,654,095.831,066,401,635.78
其他非流动金融资产26,500,00026,500,00026,500,00026,500,000
投资性房地产467,925,335.33463,953,038.77440,040,580.08387,507,016.45
固定资产3,908,799,918.13,991,276,420.924,049,534,377.674,120,888,129.03
在建工程584,448,146.14533,097,328.96541,283,433.55487,657,647.8
使用权资产326,610,321.75338,472,348.46362,963,401.57378,194,124.2
无形资产2,007,878,697.482,018,616,893.911,701,520,199.791,693,059,535.4
开发支出1,036,658,214.621,020,885,502.671,008,359,063.69985,038,877.38
商誉3,619,848,802.323,619,848,802.323,841,657,674.793,752,478,309.76
长期待摊费用288,924,196.62290,734,919.11310,650,492.41287,065,646.9
递延所得税资产308,570,163.35314,866,760.31166,667,350.55191,476,457.45
其他非流动资产1,358,299,520.611,241,718,372.471,522,322,713.211,445,823,443.87
非流动资产平衡项目0000
非流动资产合计16,226,547,058.8516,136,818,495.5716,273,648,200.0716,083,343,504.98
资产平衡项目0000
资产总计25,233,363,806.4624,573,100,199.1925,006,284,390.125,296,397,719.6
流动负债:
短期借款287,470,323.14301,656,435.95354,371,906.571,130,116,873.25
交易性金融负债196,887.0993,983.38--
应付票据及应付账款842,450,853.98797,153,743.4620,859,275.37703,410,867.1
其中:应付票据81,611,740.2187,698,748.8895,442,845.1688,452,450.06
应付账款760,839,113.77709,454,994.52525,416,430.21614,958,417.04
合同负债248,092,460.24242,043,458.27237,507,441.67227,997,563.1
应付职工薪酬46,931,532.6885,548,165.1962,297,871.1759,493,634.45
应交税费187,654,171.33135,655,297.65113,184,344.96119,061,729.61
其他应付款合计443,435,003.43397,963,800.74463,554,853.84499,152,495.66
应付股利2,649,356.313,071,231.3121,753,503.5630,127,944.38
一年内到期的非流动负债2,841,444,978.841,591,697,242.05710,367,999.34551,122,320.17
其他流动负债58,740,146.6660,739,818.0265,538,130.7467,186,280.71
流动负债平衡项目0000
流动负债合计4,956,416,357.393,612,551,944.652,627,681,823.663,357,541,764.05
非流动负债:
长期借款2,521,979,011.722,015,583,172.322,860,653,053.852,290,905,446.63
应付债券-1,608,915,230.871,592,677,302.711,576,429,482.66
租赁负债250,426,167.18251,912,745.16288,732,716.72292,088,819.62
递延收益141,625,048.15137,907,778.27148,406,712.28149,510,756.11
递延所得税负债203,689,282.55205,793,013186,831,475.44189,266,143.2
非流动负债平衡项目0000
非流动负债合计3,117,719,509.64,220,111,939.625,077,301,2614,498,200,648.22
负债平衡项目0000
负债合计8,074,135,866.997,832,663,884.277,704,983,084.667,855,742,412.27
所有者权益(或股东权益):
实收资本(或股本)1,880,611,0821,880,611,0051,880,610,5991,880,610,558
其他权益工具214,746,865.47214,747,153.96214,748,648.84214,748,806.19
资本公积3,554,749,412.413,533,592,427.33,527,580,539.853,518,190,904.22
减:库存股608,492,292.32608,492,292.32608,492,292.32555,923,164.15
其他综合收益-24,584,399.43-41,347,794.62-92,228,667.37-181,249,261.34
盈余公积787,909,316.71787,909,316.71732,541,206.45732,541,206.45
未分配利润9,810,888,030.669,434,401,562.7910,142,517,243.2710,282,080,002.67
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计15,615,828,015.515,201,421,378.8215,797,277,277.7215,890,999,052.04
少数股东权益1,543,399,923.971,539,014,936.11,504,024,027.721,549,656,255.29
股东权益平衡项目0000
股东权益合计17,159,227,939.4716,740,436,314.9217,301,301,305.4417,440,655,307.33
负债和股东权益合计25,233,363,806.4624,573,100,199.1925,006,284,390.125,296,397,719.6
公告日期2025-04-192025-04-192024-10-262024-08-24
审计意见(境内)标准无保留意见
TOP↑